Trial Profile
A Phase 1 Study of VX-150 Intravenous Formulation for the Treatment of Acute Pain
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 19 Feb 2018
Price :
$35
*
At a glance
- Drugs VX 150 (Primary)
- Indications Pain
- Focus Adverse reactions
- 19 Feb 2018 New trial record